Ƶ
Back to
Dr Andrea Schaffer

Dr Andrea Schaffer

Adjunct Senior Lecturer

PhD, University of New South Wales, Australia (2017)

MBiostat, University of Sydney, Australia (2011)

MSc(Epidemiology), McGill University, Canada (2004)

BSc(Hons)(Microbiology and Immunology), McGill University, Canada (2001)

Medicine & Health
School of Population Health

Google Scholar

Twitter
E-mail
andrea.schaffer@unsw.edu.au
Location
Centre for Big Data Research Level 2, AGSM Building (G27)
  • Book Chapters | 2012
    Roach ; Williams G; Hor M; Ramraj V, 2012, 'Introduction', in Ramraj V; Hor M; Roach K (ed.), Global Anti-Terrorism Law and Policy, Cambridge University Press, UK, pp. 1 - 17
  • Journal articles | 2024
    Brown AD; Fisher L; Curtis HJ; Wiedemann M; Hulme WJ; Speed V; Hopcroft LEM; Cunningham C; Costello RE; Galloway JB; Russell MD; Bechman K; Kurt Z; Croker R; Wood C; Walker AJ; Schaffer AL; Bacon SCJ; Mehrkar A; Hickman G; Bates C; Cockburn J; Parry J; Hester F; Harper S; Goldacre B; MacKenna B, 2024, 'OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate', British Journal of Clinical Pharmacology,
    Journal articles | 2024
    Camacho X; Schaffer AL; Brett J; Pratt N; Buckley NA; Henry D; Pearson SA, 2024, 'Quality use of publicly subsidised tapentadol in Australia: a population-based analysis', Internal Medicine Journal, 54, pp. 941 - 950,
    Journal articles | 2024
    Carlile O; Briggs A; Henderson AD; Butler-Cole BFC; Tazare J; Tomlinson LA; Marks M; Jit M; Lin LY; Bates C; Parry J; Bacon SCJ; Dillingham I; Dennison WA; Costello RE; Walker AJ; Hulme W; Goldacre B; Mehrkar A; MacKenna B; Green A; Schaffer A; Brown A; Morton C; Walters C; Stables C; Cunningham C; Wood C; Andrews C; Evans D; Hickman G; Curtis H; Drysdale H; Morley J; Massey J; Nab L; Hopcroft L; Fisher L; Bridges L; Wiedemann M; DeVito N; Macdonald O; Inglesby P; Smith R; Croker R; Park R; Higgins R; Davy S; Maude S; O'Dwyer T; Ward T; Speed V; Hart L; Stokes P; Bhaskaran K; Cowling T; Douglas I; Eggo RM; Evans S; Forbes H; Grieve R; Grint D; Herrett E; Langan S; Mahalingasivam V; Mansfield K; Mathur R; McDonald H; Parker E; Rentsch C; Schultze A; Smeeth L; Walker J; Williamson E; Wing K; Wong A; Zheng B; Cockburn J; Hester F; Harper S; O'Hanlon S; Eavis A; Jarvis R; Avramov D; Griffiths P; Fowles A; Parkes N; Perera R; Harrison D; Khunti K; Sterne J; Quint J, 2024, 'Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)', The Lancet Regional Health - Europe, 40,
    Journal articles | 2024
    Cohen JM; Alvestad S; Suarez EA; Schaffer A; Selmer RM; Havard A; Bateman BT; Cesta CE; Zoega H; Odsbu I; Huybrechts KF; Kjerpeseth LJ; Straub L; Leinonen MK; Bjørk MH; Nørgaard M; Gissler M; Ulrichsen SP; Hernandez-Diaz S; Tomson T; Furu K, 2024, 'Comparative Risk of Major Congenital Malformations With Antiseizure Medication Combinations vs Valproate Monotherapy in Pregnancy', Neurology, 102,
    Journal articles | 2024
    Deakin CT; Costa JDO; Brieger D; Lin J; Schaffer AL; Kidd M; Pearson S-A; Falster MO, 2024, 'Post-discharge pharmacotherapy in people with atrial fibrillation hospitalised for acute myocardial infarction: an Australian cohort study 2018-2022.', Eur Heart J Qual Care Clin Outcomes,
    Journal articles | 2024
    Henderson AD; Butler-Cole BF; Tazare J; Tomlinson LA; Marks M; Jit M; Briggs A; Lin LY; Carlile O; Bates C; Parry J; Bacon SC; Dillingham I; Dennison WA; Costello RE; Wei Y; Walker AJ; Hulme W; Goldacre B; Mehrkar A; MacKenna B; Green A; Schaffer A; Brown A; Morton C; Walters C; Stables C; Cunningham C; Wood C; Andrews C; Evans D; Hickman G; Curtis H; Drysdale H; Morley J; Massey J; Nab L; Hopcroft L; Fisher L; Bridges L; Wiedemann M; DeVito N; Macdonald O; Inglesby P; Smith R; Croker R; Park R; Higgins R; Davy S; Maude S; O'Dwyer T; Ward T; Speed V; Hart L; Stokes P; Bhaskaran K; Cowling T; Douglas I; Eggo RM; Evans S; Forbes H; Grieve R; Grint D; Herrett E; Langan S; Mahalingasivam V; Mansfield K; Mathur R; McDonald H; Parker E; Rentsch C; Schultze A; Smeeth L; Walker J; Williamson E; Wing K; Wong A; Zheng B; Cockburn J; Hester F; Harper S; O'Hanlon S; Eavis A; Jarvis R; Avramov D; Griffiths P; Fowles A; Parkes N; Perera R; Harrison D; Khunti K; Sterne J; Quint J, 2024, 'Clinical coding of long COVID in primary care 2020–2023 in a cohort of 19 million adults: an OpenSAFELY analysis', eClinicalMedicine, 72,
    Journal articles | 2024
    Lin J; De Oliveira Costa J; Pearson SA; Buckley NA; Brieger D; Schutte AE; Schaffer AL; Falster MO, 2024, 'Impact of coordinated care on adherence to antihypertensive medicines among adults experiencing polypharmacy in Australia', Journal of Hypertension, 42, pp. 1248 - 1255,
    Journal articles | 2024
    Nab L; Schaffer AL; Hulme W; DeVito NJ; Dillingham I; Wiedemann M; Andrews CD; Curtis H; Fisher L; Green A; Massey J; Walters CE; Higgins R; Cunningham C; Morley J; Mehrkar A; Hart L; Davy S; Evans D; Hickman G; Inglesby P; Morton CE; Smith RM; Ward T; O'Dwyer T; Maude S; Bridges L; Butler-Cole BFC; Stables CL; Stokes P; Bates C; Cockburn J; Hester F; Parry J; Bhaskaran K; Schultze A; Rentsch CT; Mathur R; Tomlinson LA; Williamson EJ; Smeeth L; Walker A; Bacon S; MacKenna B; Goldacre B, 2024, 'OpenSAFELY: A platform for analysing electronic health records designed for reproducible research', Pharmacoepidemiology and Drug Safety, 33,
    Journal articles | 2024
    Samuel M; Park RY; Eastwood SV; Eto F; Morton CE; Stow D; Bacon S; Mehrkar A; Morley J; Dillingham I; Inglesby P; Hulme WJ; Khunti K; Mathur R; Valabhji J; MacKenna B; Finer S; Walker AJ; Green ACA; Schaffer AL; Brown AD; Goldacre B; Butler-Cole BFC; Walters CE; Stables CL; Cunningham C; Bates C; Wood C; Andrews CD; Evans D; Hester F; Hickman G; Curtis HJ; Drysdale H; Massey J; Cock-Burn J; Parry J; Hart LC; Nab L; Hopcroft LEM; Fisher L; Bridges L; Wiedemann M; DeVito NJ; Macdonald O; Stokes P; Smith RM; Croker R; Higgins R; Harper S; Davy S; Maude S; O'Dwyer T; Ward T; Speed V, 2024, 'Trends in weight gain recorded in English primary care before and during the Coronavirus-19 pandemic: An observational cohort study using the OpenSAFELY platform', PLoS Medicine, 21,
    Journal articles | 2024
    Schaffer AL; Andrews CD; Brown AD; Croker R; Hulme WJ; Nab L; Quinlan J; Speed V; Wood C; Wiedemann M; Massey J; Inglesby P; Bacon SCJ; Mehrkar A; Bates C; Goldacre B; Walker AJ; MacKenna B; Bridges L; Butler-Cole BF; Davy S; Dillingham I; Evans D; Fisher L; Green A; Hart L; Hickman G; Maude S; O'Dwyer T; Smith RM; Stokes P; Ward T; Cockburn J; Harper S; Hester F; Parry J, 2024, 'Changes in opioid prescribing during the COVID-19 pandemic in England: an interrupted time-series analysis in the OpenSAFELY-TTP cohort', The Lancet Public Health, 9, pp. e432 - e442,
    Journal articles | 2024
    Schaffer AL; Buckley NA; Schumann J; Lim JS; Cairns R; Raubenheimer J; Pearson SA; Chitty K, 2024, 'Patterns of medicine use in the year prior to death by suicide: an Australian population-based case series study', eClinicalMedicine, 77,
    Journal articles | 2024
    Schaffer AL; Park RY; Tazare J; Bhaskaran K; Mackenna B; Denaxas S; Dillingham I; Bacon SCJ; Mehrkar A; Bates C; Goldacre B; Greaves F; Macleod J; Tomlinson LA; Walker A, 2024, 'Changes in sick notes associated with COVID-19 from 2020 to 2022: A cohort study in 24 million primary care patients in OpenSAFELY-TPP', BMJ Open, 14,
    Journal articles | 2024
    Wood C; Speed V; Fisher L; Curtis HJ; Schaffer AL; Walker AJ; Croker R; Brown AD; Cunningham C; Hulme WJ; Andrews CD; Butler-Cole BFC; Evans D; Inglesby P; Dillingham I; Bacon SCJ; Davy S; Ward T; Hickman G; Bridges L; O'Dwyer T; Maude S; Smith RM; Mehrkar A; Bates C; Cockburn J; Parry J; Hester F; Harper S; Goldacre B; MacKenna B, 2024, 'The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records', British Journal of Clinical Pharmacology, 90, pp. 1600 - 1614,
    Journal articles | 2024
    Zoega H; Falster M; Gillies M; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer A; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic C; Pearson SA, 2024, 'The Medicines Intelligence Data Platform: A Population-Based Data Resource From New South Wales, Australia', Pharmacoepidemiology and Drug Safety, 33,
    Journal articles | 2023
    Ainsworth B; Horwood J; Walter SR; Miller S; Chalder M; De Vocht F; Denison-Day J; Elwenspoek MMC; Curtis HJ; Bates C; Mehrkar A; Bacon S; Goldacre B; Walker AJ; MacKenna B; Inglesby P; Morton CE; Morley J; Hickman G; Croker R; Evans D; Ward T; DeVito NJ; Fisher L; Green ACA; Massey J; Smith RM; Hulme WJ; Davy S; Andrews CD; Hopcroft LEM; Drysdale H; Dillingham I; Park RY; Higgins R; Cunningham C; Wiedemann M; Nab L; Maude S; Butler-Cole BFC; O’Dwyer T; Stables CL; Wood C; Brown AD; Speed V; Bridges L; Schaffer AL; Walters CE; Rentsch CT; Bhaskaran K; Schultze A; Williamson EJ; McDonald HI; Tomlinson LA; Eggo RM; Wing K; Wong AYS; Tazare J; Grint DJ; Langan S; Mansfield KE; Douglas IJ; Evans SJW; Smeeth L; Walker JL; Mahalingasivam V; Cowling TE; Herrett EL; Costello RE; Zheng B; Parker EPK; Mathur R; Forbes H; Cockburn J; Parry J; Hester F; Harper S; Craggs P; Amlôt R; Francis N; Little P; Macleod J; Moore M; Morton K; Rice C; Sterne J; Stuart B; Towler L; Willcox ML; Yardley L, 2023, 'Implementing Germ Defence digital behaviour change intervention via all primary care practices in England to reduce respiratory infections during the COVID-19 pandemic: an efficient cluster randomised controlled trial using the OpenSAFELY platform', Implementation Science, 18,
    Journal articles | 2023
    Carland JE; Stacy AE; Schaffer AL; Day RO; Brett J; Reuter SE; Stocker SL, 2023, 'Blood, dose recommendation reports and phone calls: Experiences of a therapeutic drug monitoring advisory service for vancomycin', British Journal of Clinical Pharmacology, 89, pp. 1896 - 1902,
    Journal articles | 2023
    Chitty KM; Buckley NA; Lim J; Ali Z; Schumann JL; Cairns R; Daniels B; Pearson SA; Preen DB; Schaffer AL, 2023, 'Psychotropic and other medicine use at time of death by suicide: a population-level analysis of linked dispensing and forensic toxicology data', Medical Journal of Australia, 219, pp. 63 - 69,
    Journal articles | 2023
    Chitty KM; Sperandei S; Carter GL; Ali Z; Raubenheimer JE; Schaffer AL; Page A; Buckley NA, 2023, 'Five healthcare trajectories in the year before suicide and what they tell us about opportunities for prevention: a population-level case series study', eClinicalMedicine, 63,
    Journal articles | 2023
    Costa JDO; Lin J; Pearson SA; Buckley NA; Schaffer AL; Falster MO; de Oliveira Costa J, 2023, 'Persistence and Adherence to Cardiovascular Medicines in Australia', Journal of the American Heart Association, 12, pp. e030264,
    Journal articles | 2023
    Costello RE; Tazare J; Herrett E; Parker EPK; Zheng B; Mansfield KE; Henderson AD; Carreira H; Bidulka P; Wong AYS; Warren-Gash C; Eggo RM; Tomlinson L; Langan SM; Mathur R; Piehlmaier D; MacKenna B; Mehrkar A; Hayes JF; Quint JK; Katikireddi SV; Chaturvedi N; Park C; Carnemolla A; Williams D; Knueppel A; Boyd A; Turner EL; Evans KM; Thomas R; Berman S; McLachlan S; Crane M; Whitehorn R; Oakley J; Foster D; Woodward H; Campbell KC; Timpson N; Kwong A; Soares AG; Griffith G; Toms R; Jones L; Annie H; Mitchell R; Palmer T; Sterne J; Walker V; Huntley L; Fox L; Denholm R; Knight R; Northstone K; Kanagaratnam A; Horne E; Forbes H; North T; Taylor K; Arab MAL; Walker S; Coronado JIC; Karthikeyan AS; Ploubidis G; Moltrecht B; Booth C; Parsons S; Wielgoszewska B; Bridger-Staatz C; Steves C; Thompson E; Garcia P; Cheetham N; Bowyer R; Freydin M; Roberts A; Goldacre B; Walker A; Morley J; Hulme W; Nab L; Fisher L; Andrews C; Curtis H; Hopcroft L; Green A; Patalay P; Maddock J; Patel K; Stafford J; Jacques W; Tilling K; Macleod J; McElroy E; Shah A; Silverwood R; Denaxas S, 2023, 'Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform', eClinicalMedicine, 61,
    Journal articles | 2023
    Gisev N; Buizen L; Hopkins RE; Schaffer AL; Daniels B; Bharat C; Dobbins T; Larney S; Blyth F; Currow DC; Wilson A; Pearson SA; Degenhardt L, 2023, 'Five-Year Trajectories of Prescription Opioid Use', JAMA Network Open, 6, pp. E2328159,
    Journal articles | 2023
    Lim JS; Buckley NA; Cairns R; Schumann J; Schaffer AL; Chitty KM, 2023, 'Substances Detected during Coroner Postmortem Toxicology Analyses in Poisoning- and Nonpoisoning-Related Suicides', JAMA Psychiatry, 80, pp. 1121 - 1130,
    Journal articles | 2023
    Meier MH; Meier MA; Anderson SF; Schaffer AL; Waddell JT; Roman BA; Poling SL; Barton EA, 2023, 'The effects of the 4/20 cannabis holiday and adult-use cannabis legalization on medical cannabis sales and medical cannabis patient registration in Arizona', International Journal of Drug Policy, 114,
    Journal articles | 2023
    Schaffer AL; Gisev N; Blyth FM; Buckley NA; Currow D; Dobbins TA; Wilson A; Degenhardt L; Pearson SA, 2023, 'Opioid prescribing patterns among medical practitioners in New South Wales, Australia', Drug and Alcohol Review, 42, pp. 1472 - 1481,
    Journal articles | 2023
    Zheng B; Tazare J; Nab L; Green AC; Curtis HJ; Mahalingasivam V; Herrett EL; Costello RE; Eggo RM; Speed V; Bacon SC; Bates C; Parry J; Cockburn J; Hester F; Harper S; Schaffer AL; Hulme WJ; Mehrkar A; Evans SJ; MacKenna B; Goldacre B; Douglas IJ; Tomlinson LA, 2023, 'Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform', The Lancet Regional Health - Europe, 34,
    Journal articles | 2023
    Zhong X; Ashiru-Oredope D; Pate A; Martin GP; Sharma A; Dark P; Felton T; Lake C; MacKenna B; Mehrkar A; Bacon SCJ; Massey J; Inglesby P; Goldacre B; Walker AJ; Curtis HJ; Morley J; Hickman G; Croker R; Evans D; Ward T; DeVito NJ; Fisher L; Green ACA; Smith RM; Hulme WJ; Davy S; Andrews CD; Hopcroft LEM; Dillingham I; Higgins R; Cunningham C; Wiedemann M; Nab L; Maude S; Macdonald O; Butler-Cole BFC; O'Dwyer T; Stables CL; Wood C; Brown AD; Speed V; Bridges L; Schaffer AL; Walters CE; Bates C; Cockburn J; Parry J; Hester F; Harper S; Hand K; Bladon S; Cunningham N; Gilham E; Brown CS; Mirfenderesky M; Palin V; van Staa TP, 2023, 'Clinical and health inequality risk factors for non-COVID-related sepsis during the global COVID-19 pandemic: a national case-control and cohort study', eClinicalMedicine, 66,
    Journal articles | 2023
    de Oliveira Costa J; Lau S; Medland N; Gibbons S; Schaffer AL; Pearson SA, 2023, 'Potential drug–drug interactions due to concomitant medicine use among people living with HIV on antiretroviral therapy in Australia', British Journal of Clinical Pharmacology, 89, pp. 1541 - 1553,
    Journal articles | 2022
    Camacho X; Schaffer A; Buckley N; Pratt N; Brett J; Henry D; Pearson S-A, 2022, 'Trends in dispensing and utilisation of sustained-release tapentadol in Australia.', International Journal of Population Data Science, 7,
    Journal articles | 2022
    Camacho X; Zoega H; Gomes T; Schaffer AL; Henry D; Pearson S-A; Vigod S; Havard A, 2022, 'The association between psychostimulant use in pregnancy and adverse maternal and neonatal outcomes: results from a distributed analysis in two similar jurisdictions.', International Journal of Epidemiology, 52, pp. 190 - 202,
    Journal articles | 2022
    Daniels B; Schaffer A; Buckley NA; Bruno C; Jun M; Pearson SA; Zoega H, 2022, 'The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis', Pharmacoepidemiology and Drug Safety, 31, pp. 370 - 378,
    Journal articles | 2022
    Falster MO; Schaffer AL; Wilson A; Nasis A; Jorm LR; Hay M; Leeb K; Pearson SA; Brieger D, 2022, 'Evidence-practice gaps in P2Y12 inhibitor use after hospitalisation for acute myocardial infarction: findings from a new population-level data linkage in Australia', Internal Medicine Journal, 52, pp. 249 - 258,
    Journal articles | 2022
    Gillies MB; Burgner DP; Ivancic L; Nassar N; Miller JE; Sullivan SG; Todd IMF; Pearson SA; Schaffer AL; Zoega H, 2022, 'Changes in antibiotic prescribing following COVID-19 restrictions: Lessons for post-pandemic antibiotic stewardship', British Journal of Clinical Pharmacology, 88, pp. 1143 - 1151,
    Journal articles | 2022
    Murnion B; Schaffer A; Cairns R; Brett J, 2022, 'Gabapentinoids: repeating mistakes of the past?', Addiction, 117, pp. 2969 - 2971,
    Journal articles | 2022
    Schaffer AL; Bruno C; Buckley NA; Cairns R; Litchfield M; Paget S; Zoega H; Nassar N; Pearson SA, 2022, 'Prescribed medicine use and extent of off-label use according to age in a nationwide sample of Australian children', Paediatric and Perinatal Epidemiology, 36, pp. 726 - 737,
    Journal articles | 2022
    Schaffer AL; Chia J; Brett J; Pearson S; Falster MO, 2022, 'A nationwide study of multimedicine use in people treated with cardiovascular medicines in Australia', Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 42, pp. 828 - 836,
    Journal articles | 2022
    Schaffer AL; Henry D; Zoega H; Elliott JH; Pearson SA, 2022, 'Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID- 19 pandemic in Australia', PLoS ONE, 17, pp. e0269482,
    Journal articles | 2022
    Tang M; Lee CK; Lewis CR; Boyer M; Brown B; Schaffer A; Pearson SA; Simes RJ, 2022, 'Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancer', Lung Cancer, 166, pp. 40 - 48,
    Journal articles | 2022
    de Oliveira Costa J; Gillies MB; Schaffer AL; Peiris D; Zoega H; Pearson SA, 2022, 'Changes in antidepressant use in Australia: A nationwide analysis (2015–2021)', Australian and New Zealand Journal of Psychiatry, 57,
    Journal articles | 2022
    de Oliveira Costa J; Zhao Y; Pearson S; Schaffer A, 2022, 'Assessing the impact of implementing multiple adherence measures to antiretroviral therapy from dispensing data: a short report', AIDS Care: psychological and socio-medical aspects of AIDS-HIV, 35, pp. 970 - 975,
    Journal articles | 2021
    Daniels B; Pearson SA; Buckley NA; Bruno C; Schaffer A; Zoega H, 2021, 'Coming to grips with seemingly conflicting results in programme evaluation: The devil's in the detail', BMJ Quality and Safety, 30, pp. 70 - 71,
    Journal articles | 2021
    De Oliveira Costa J; Bruno C; Schaffer AL; Raichand S; Karanges EA; Pearson SA, 2021, 'The changing face of Australian data reforms: Impact on pharmacoepidemiology research', International Journal of Population Data Science, 6, pp. 1418,
    Journal articles | 2021
    Schaffer AL; Busingye D; Chidwick K; Brett J; Blogg S, 2021, 'Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study', BJGP Open, 5, pp. 1 - 10,
    Journal articles | 2021
    Schaffer AL; Dobbins TA; Pearson SA, 2021, 'Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions', BMC Medical Research Methodology, 21, pp. 58,
    Journal articles | 2021
    Stocker SL; Carland JE; Reuter SE; Stacy AE; Schaffer AL; Stefani M; Lau C; Kirubakaran R; Yang JJ; Shen CFJ; Roberts DM; Marriott DJE; Day RO; Brett J, 2021, 'Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis', Clinical Pharmacology and Therapeutics, 109, pp. 212 - 221,
    Journal articles | 2021
    Tang M; Daniels B; Aslam M; Schaffer A; Pearson SA, 2021, 'Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study', The Lancet Regional Health - Western Pacific, 14, pp. 100226,
    Journal articles | 2021
    Tang M; Daniels B; Schaffer AL; Pearson SA, 2021, 'Real-world data to advance HER2-targeted cancer medicines research: Playing to the strengths of clinical registry and administrative data', Asia-Pacific Journal of Clinical Oncology, 17, pp. 414 - 415,
    Journal articles | 2021
    Tang M; Pearson SA; Schaffer AL; Lewis CR; John T; Simes RJ; Lee CK, 2021, 'Are clinical trial eligibility criteria representative of older patients with lung cancer? A population-based data linkage study', Journal of Geriatric Oncology, 12, pp. 930 - 936,
    Journal articles | 2021
    Tang M; Schaffer AL; Kiely BE; Daniels B; Lee CK; Simes RJ; Pearson SA, 2021, 'Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based study', Breast Cancer Research and Treatment, 187, pp. 893 - 902,
    Journal articles | 2021
    Tervonen HE; Schaffer AL; Luckett T; Phillips J; Litchfield M; Todd A; Pearson SA, 2021, 'Patterns of opioid use in older people diagnosed with cancer in New South Wales, Australia', Pharmacoepidemiology and Drug Safety, 30, pp. 360 - 370,
    Journal articles | 2021
    Welberry HJ; Jorm LR; Schaffer AL; Barbieri S; Hsu B; Harris MF; Hall J; Brodaty H, 2021, 'Psychotropic medicine prescribing and polypharmacy for people with dementia entering residential aged care: the influence of changing general practitioners', Medical Journal of Australia, 215, pp. 130 - 136,
    Journal articles | 2020
    Bruno C; Pearson SA; Daniels B; Buckley NA; Schaffer A; Zoega H, 2020, 'Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia', BMJ Quality and Safety, 29, pp. 365 - 373,
    Journal articles | 2020
    Cairns R; Schaffer AL; Brown JA; Pearson SA; Buckley NA, 2020, 'Codeine use and harms in Australia: evaluating the effects of re-scheduling', Addiction, 115, pp. 451 - 459,
    Journal articles | 2020
    Chitty KM; Schumann JL; Schaffer A; Cairns R; Gonzaga NJ; Raubenheimer JE; Carter G; Page A; Pearson SA; Buckley NA, 2020, 'Australian Suicide Prevention using Health-Linked Data (ASHLi): Protocol for a population-based case series study', BMJ Open, 10, pp. e038181,
    Journal articles | 2020
    Chiu T; Brett J; Pearson S; Schaffer A, 2020, 'Patterns of pregabalin initiation and discontinuation after its subsidy in Australia', British Journal of Clinical Pharmacology, 86, pp. 1882 - 1887,
    Journal articles | 2020
    Cohen JM; Cesta CE; Furu K; Einarsdóttir K; Gissler M; Havard A; Hernandez-Diaz S; Huybrechts KF; Kieler H; Leinonen MK; Li J; Reutfors J; Schaffer A; Selmer R; Yu Y; Zoega H; Karlstad Ø, 2020, 'Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006-2016: A study in the five Nordic countries, United States, and Australia', Pharmacoepidemiology and Drug Safety, 29, pp. 913 - 922,
    Journal articles | 2020
    De Oliveira Costa J; Schaffer AL; Medland NA; Litchfield M; Narayan SW; Guy R; McManus H; Pearson SA, 2020, 'Adherence to Antiretroviral Regimens in Australia: A Nationwide Cohort Study', AIDS Patient Care and STDs, 34, pp. 81 - 91,
    Journal articles | 2020
    Hsu B; Falster MO; Schaffer AL; Pearson S; Jorm L; Brieger DB, 2020, 'Antiplatelet therapy within 30 days of percutaneous coronary intervention with stent implantation', Medical Journal of Australia, 213, pp. 124 - 125,
    Journal articles | 2020
    Reutfors J; Cesta CE; Cohen JM; Bateman BT; Brauer R; Einarsdóttir K; Engeland A; Furu K; Gissler M; Havard A; Hernandez-Diaz S; Huybrechts KF; Karlstad Ø; Leinonen MK; Li J; Man KKC; Pazzagli L; Schaffer A; Schink T; Wang Z; Yu Y; Zoega H; Bröms G, 2020, 'Antipsychotic drug use in pregnancy: A multinational study from ten countries', Schizophrenia Research, 220, pp. 106 - 115,
    Journal articles | 2020
    Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson SA, 2020, 'Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine', Medical Journal of Australia, 212, pp. 321 - 327,
    Journal articles | 2020
    Schaffer AL; Pearson SA; Perez-Concha O; Dobbins T; Ward RL; Leeuwen MTV; Rhee JJ; Laaksonen MA; Craigen G; Vajdic CM; van Leeuwen M, 2020, 'Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP)', PLoS ONE, 15, pp. e0230373,
    Journal articles | 2020
    Tang M; Schaffer A; Kiely BE; Daniels B; Simes RJ; Lee CK; Pearson SA, 2020, 'Correction: Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016) (British Journal of Cancer, (2019), 121, 11, (904-911), 10.1038/s41416-019-0612-5)', British Journal of Cancer, 123, pp. 868,
    Journal articles | 2020
    Zheng D; Brett J; Daniels B; Buckley NA; Pearson SA; Schaffer AL, 2020, 'Potentially inappropriate benzodiazepine use in Australian adults: A population-based study (2014–2017)', Drug and Alcohol Review, 39, pp. 575 - 582,
    Journal articles | 2019
    Cairns R; Schaffer AL; Ryan N; Pearson SA; Buckley NA, 2019, 'Monitoring emerging prescription-drug related harms: a comment on Cairns et al. (2018)—in reply', Addiction, 114, pp. 572 - 573,
    Journal articles | 2019
    Han D; Narayan SW; Zoega H; Litchfield M; Buckley NA; Pearson SA; Schaffer AL, 2019, 'Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debate', Pharmacoepidemiology and Drug Safety, 28, pp. 521 - 527,
    Journal articles | 2019
    Schaffer AL; Buckley NA; Cairns R; Pearson S, 2019, 'Comparison of Prescribing Patterns before and after Implementation of a National Policy to Reduce Inappropriate Alprazolam Prescribing in Australia', JAMA Network Open, 2, pp. e1911590,
    Journal articles | 2019
    Schaffer AL; Falster MO; Brieger D; Jorm LR; Wilson A; Hay M; Leeb K; Pearson S; Nasis A, 2019, 'Evidence-practice gaps in postdischarge initiation with oral anticoagulants in patients with atrial fibrillation', Journal of the American Heart Association, 8, pp. e014287,
    Journal articles | 2019
    Schaffer AL; Karanges EA; Buckley NA; Wilson A; Degenhardt L; Larance B; Pearson SA, 2019, 'Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study', Pharmacoepidemiology and Drug Safety, 28, pp. 97 - 105,
    Journal articles | 2019
    Schaffer AL; Zoega H; Tran DT; Buckley NA; Pearson S; Havard A, 2019, 'Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristics', Australian & New Zealand Journal of Psychiatry, 53, pp. 000486741984776 - 000486741984776,
    Journal articles | 2019
    Tang M; Schaffer A; Kiely BE; Daniels B; Simes RJ; Lee CK; Pearson SA, 2019, 'Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007–2016)', British Journal of Cancer, 121, pp. 904 - 911,
    Journal articles | 2019
    Tang M; Schaffer A; Pearson SA, 2019, 'Embracing the full spectrum of real-world data for cancer medicines research in Australia', Asia-Pacific Journal of Clinical Oncology, 15, pp. 186 - 187,
    Journal articles | 2019
    Vajdic CM; Perez-Concha O; Dobbins T; Ward RL; Schaffer AL; van Leeuwen MT; Rhee JJ; Laaksonen MA; Craigen G; Pearson SA, 2019, 'Demographic, social and lifestyle risk factors for cancer registry-notified cancer of unknown primary site (CUP)', Cancer Epidemiology, 60, pp. 156 - 161,
    Journal articles | 2019
    Vajdic CM; Perez-Concha O; Rhee JJ; Dobbins T; Ward RL; Schaffer AL; van Leeuwen MT; Laaksonen MA; Craigen G; Pearson SA, 2019, 'Health-related predictors of cancer registry-notified cancer of unknown primary site (CUP)', Cancer Epidemiology, 61, pp. 1 - 7,
    Journal articles | 2018
    Brett J; Schaffer A; Dobbins T; Buckley NA; Pearson SA, 2018, 'The impact of permissive and restrictive pharmaceutical policies on quetiapine dispensing: Evaluating a policy pendulum using interrupted time series analysis', Pharmacoepidemiology and Drug Safety, 27, pp. 439 - 446,
    Journal articles | 2018
    Cairns R; Schaffer A; Ryan N; Pearson S; Buckley NA, 2018, 'Rising pregabalin use and misuse in Australia: trends in utilisation and intentional poisonings', Addiction, 114, pp. 1026 - 1034,
    Journal articles | 2018
    Morgan A; Joshy G; Schaffer A; Laba T-L; Litchfield M; Pearson S; Banks E, 2018, 'Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants', PLoS ONE, 13, pp. e0208824,
    Journal articles | 2018
    Schaffer A; Buckley NA; Degenhardt L; Larance B; Cairns R; Dobbins T; Pearson SA, 2018, 'Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia', Canadian Medical Association Journal, 190, pp. E355 - E362,
    Journal articles | 2017
    Joshi V; Adelstein BA; Schaffer A; Srasuebkul P; Dobbins T; Pearson SA, 2017, 'Validating a proxy for disease progression in metastatic cancer patients using prescribing and dispensing data', Asia-Pacific Journal of Clinical Oncology, 13, pp. e246 - e252,
    Journal articles | 2017
    Schaffer AL; Buckley NA; Pearson SA, 2017, 'Who benefits from fixed-dose combinations? Two-year statin adherence trajectories in initiators of combined amlodipine/atorvastatin therapy', Pharmacoepidemiology and Drug Safety, 26, pp. 1465 - 1473,
    Journal articles | 2016
    Schaffer AL; Buckley NA; Cairns R; Pearson SA, 2016, 'Interrupted time series analysis of the effect of rescheduling alprazolam in Australia: Taking control of prescription drug use', JAMA Internal Medicine, 176, pp. 1223 - 1225,
    Journal articles | 2016
    Schaffer AL; Pearson SA; Buckley NA, 2016, 'How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006–2014)', British Journal of Clinical Pharmacology, 82, pp. 1134 - 1145,
    Journal articles | 2015
    Ganda K; Schaffer A; Seibel MJ, 2015, 'Predictors of re-fracture amongst patients managed within a secondary fracture prevention program: a 7-year prospective study', Osteoporosis International, 26, pp. 543 - 551,
    Journal articles | 2015
    Gnjidic D; Pearson SA; Hilmer SN; Basilakis J; Schaffer AL; Blyth FM; Banks E, 2015, 'Manual versus automated coding of free-text self-reported medication data in the 45 and Up Study: A validation study', Public Health Research and Practice, 25,
    Journal articles | 2015
    Mellish L; Karanges EA; Litchfield MJ; Schaffer AL; Blanch B; Daniels BJ; Segrave A; Pearson SA, 2015, 'The Australian Pharmaceutical Benefits Scheme data collection: A practical guide for researchers', BMC Research Notes, 8, pp. 634,
    Journal articles | 2015
    Schaffer AL; Buckley NA; Dobbins TA; Banks E; Pearson SA, 2015, 'The crux of the matter: Did the ABC’s catalyst program change Statin use in Australia?', Medical Journal of Australia, 202, pp. 591 - 595,
    Journal articles | 2015
    Schaffer AL; Pearson SA; Dobbins TA; Er CC; Ward RL; Vajdic CM, 2015, 'Patterns of care and survival after a cancer of unknown primary (CUP) diagnosis: A population-based nested cohort study in Australian Government Department of Veterans' Affairs clients', Cancer Epidemiology, 39, pp. 578 - 584,
    Journal articles | 2015
    Vajdic CM; Ward RL, 2015, 'Health service utilisation and investigations before diagnosis of cancer of unknown primary (CUP): A population-based nested case-control study in Australian Government Department of Veterans' Affairs client', Cancer Epidemiology, 39, pp. 585 - 592
    Journal articles | 2014
    Ganda K; Schaffer A; Pearson S; Seibel MJ, 2014, 'Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: A randomised controlled trial of specialist vs. non-specialist management', Osteoporosis International, 25, pp. 1345 - 1355,
    Journal articles | 2014
    Pearson SA; Schaffer A, 2014, 'The use and impact of cancer medicines in routine clinical care: Methods and observations in a cohort of elderly Australians', BMJ Open, 4, pp. e004099,
    Journal articles | 2014
    Vajdic CM; Er CC; Schaffer A; Dobbins T; Wyld L; Meagher NS; Barrett J; Ward RL; Pearson SA, 2014, 'An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data', Cancer Epidemiology, 38, pp. 460 - 464,
    Journal articles | 2013
    Joshi V; Adelstein B-A; Schaffer A; Srasuebkul P; Dobbins T; Pearson S-A, 2013, 'A Proxy of Cancer Progression in Dispensing Claims: Validation and Performance', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 22, pp. 221 - 222,
    Journal articles | 2012
    Schaffer A; Muscatello D; Broome R; Corbett S; Smith W, 2012, 'Emergency department visits, ambulance calls, and mortality associated with an exceptional heat wave in Sydney, Australia, 2011: A time-series analysis', Environmental Health: A Global Access Science Source, 11, pp. 3,
    Journal articles | 2012
    Schaffer A; Muscatello D; Cretikos M; Gilmour R; Tobin S; Ward J, 2012, 'The impact of influenza A(H1N1)pdm09 compared with seasonal influenza on intensive care admissions in New South Wales, Australia, 2007 to 2010: A time series analysis', BMC Public Health, 12, pp. 869,
    Journal articles | 2007
    Brotherton J; Wang H; Schaffer A; Quinn H; Menzies R; Hull B; Lawrence GL; Wood J; Wood N; Rosewell A; Newall AT; MacIntyre CR; Macartney K; Gidding HF; McIntyre P; Booy R, 2007, 'Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005', Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended, 31, pp. S1 - S152
    Journal articles | 2007
    Schaffer A; Brotherton J; Booy R, 2007, 'Do human papillomavirus vaccines have any role in newborns and the prevention of recurrent respiratory papillomatosis in children?', Journal of Paediatrics and Child Health, 43, pp. 579 - 580,
    Journal articles | 2007
    Schaffer A; Koushik A; Trottier H; Duarte-Franco E; Mansour N; Arseneau J; Provencher D; Gilbert L; Gotlieb W; Ferenczy A; Coutlée F; Pollak MN; Franco EL; Matlashewski G; Roger M; Piché S; Capek A; Juras A; Michon B; Florakas C; Landry D; Grandmont D; L'Heureux D; Dalton D; Queiros E; Dauth E; Leclerc F; Stanimir G; Hum HS; Czitrom JP; Dubuc-Lissoir J; Lord J; Mayrand MH; Dupuis MJ; Martin M; Roleau M; Plamondon M; Fournier P; Gauthier P; Drouin P; Fournier P; Jeanbart P; Shatz R; Piché R; Hunt R, 2007, 'Insulin-like growth factor-I and risk of high-grade cervical intraepithelial neoplasia', Cancer Epidemiology Biomarkers and Prevention, 16, pp. 716 - 722,
  • Preprints | 2024
    Andrews C; Prestige E; Parker EPK; Walker V; Palmer T; Schaffer A; Green ACA; Curtis H; Walker A; Smith R; Wood C; Bates C; Mehrkar A; MacKenna B; Bacon SCJ; Goldacre B; Hernán M; Sterne JAC; the OpenSAFELY collaborative ; Hulme W, 2024, Comparative safety and effectiveness of Pfizer BA.4-5 versus Sanofi during the spring 2023 COVID-19 booster vaccination programme in England: a matched cohort study in OpenSAFELY-TPP,
    Preprints | 2024
    Andrews CD; Parker EPK; Horne E; Walker V; Palmer T; Schaffer AL; Green ACA; Curtis HJ; Walker AJ; Bridges L; Wood C; Speed V; Bates C; Cockburn J; Parry J; Mehrkar A; MacKenna B; Bacon SCJ; Goldacre B; Hernan MA; Sterne JAC; Hulme WJ, 2024, OpenSAFELY: Effectiveness of COVID-19 vaccination in children and adolescents,
    Preprints | 2024
    Cunningham C; Macdonald O; Schaffer A; Brown A; Wiedemann M; Higgins R; Bates C; Parry J; Fisher L; Curtis H; Mehrkar A; Hart L; Bacon S; Hulme W; Speed V; Ward T; Croker R; Wood C; Walker A; Andrews C; Butler-Cole B; Evans D; Inglesby P; Dillingham I; Davy S; Bridges L; O’Dwyer T; Maude S; Smith R; Goldacre B; MacKenna B, 2024, The impact of the COVID-19 pandemic on Antidepressant Prescribing with a focus on people with learning disability and autism: An interrupted time-series analysis in England using OpenSAFELY-TPP,
    Preprints | 2024
    Zoega H; Falster M; Gillies M; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer A; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic C; Pearson S-A, 2024, The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia,
    Preprints | 2023
    Schaffer A; Park R; Tazare J; Bhaskaran K; MacKenna B; Denaxas S; Denaxas S; Dillingham I; Bacon SCJ; Mehrkar A; Bates C; Goldacre B; Greaves F; Macleod J; The OpenSAFELY Collaborative ; National Core Studies Collaborative ; Tomlinson L; Walker A, 2023, Fit notes associated with COVID-19 in 24 million patients’ primary care records: A cohort study in OpenSAFELY-TPP,
    Preprints | 2023
    The OpenSAFELY Collaborative ; Brown A; Fisher L; Curtis H; Wiedemann M; Hulme W; Hopcroft LEM; Cunningham C; Speed V; Costello R; Galloway J; Russell M; Bechman K; Kurt Z; Croker R; Wood C; Walker A; Schaffer A; Bacon SCJ; Mehrkar A; Hickman G; Bates C; Cockburn J; Parry J; Hester F; Harper S; Goldacre B; MacKenna B, 2023, OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide, and methotrexate monitoring, and factors associated with change in monitoring rate,
    Preprints | 2023
    The OpenSAFELY Collaborative ; Wood C; Speed V; Fisher L; Curtis H; Schaffer A; Walker A; Croker R; Brown A; Cunningham C; Hulme W; Andrews C; Butler-Cole B; Evans D; Inglesby P; Dillingham I; Bacon SCJ; Davy S; Ward T; Hickman G; Bridges L; O’Dwyer T; Maude S; Smith R; Mehrkar A; Bates C; Cockburn J; Parry J; Hester F; Harper S; Goldacre B; MacKenna B, 2023, The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records,
    Preprints | 2023
    The OpenSAFELY collaborative ; Tazare J; Nab L; Zheng B; Hulme W; Green A; Curtis H; Mahalingasivam V; Higgins R; Schultze A; Bhaskaran K; Mehrkar A; Schaffer A; Smith R; Bates C; Cockburn J; Parry J; Hester F; Harper S; Eggo R; Walker A; Marks M; Brown M; Maringe C; Leyrat C; Evans S; Goldacre B; MacKenna B; Sterne J; Tomlinson L; Douglas I, 2023, Effectiveness of Sotrovimab and Molnupiravir in community settings in England across the Omicron BA.1 and BA.2 sublineages: emulated target trials using the OpenSAFELY platform,
    Conference Abstracts | 2022
    Camacho X; Schaffer A; Buckley NA; Pratt N; Henry D; Pearson S-A, 2022, 'Trends in dispensing and utilization of tapentadol in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 543 - 544,
    Conference Abstracts | 2022
    Chitty K; Buckley N; Lim J; Ali Z; Schumann J; Cairns R; Daniels B; Preen D; Schaffer A, 2022, 'An overview of psychotropic pharmacotherapy at time of death by suicide: An Australian-wide case series study using administrative and coronial data', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 71 - 72,
    Conference Papers | 2022
    Gisev N; Buizen L; Schaffer A; Daniels B; Pearson S-A; Dobbins T; Blyth F; Larney S; Currow DC; Wilson A; Degenhardt L, 2022, '| New South Wales, Long-term trajectories of prescription opioid use in New South Wales, Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 371 - 372,
    Conference Abstracts | 2022
    Schaffer A; Buckley NA; Schumann J; Lim J; Cairns R; Chitty K, 2022, 'Patterns of psychotropic medicine use and initiation in the year prior to death by suicide: A population-based study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 366 - 366,
    Conference Abstracts | 2022
    Schaffer AL; Brett J; Buckley NA; Pearson SA, 2022, 'Trajectories of pregabalin use and their association with longitudinal changes in opioid and benzodiazepine use', in Pain, Wolters Kluwer, United States, Vol. 163, pp. E614 - E621, United States,
    Conference Papers | 2022
    Tang M; Lee C; Lewis C; Boyer M; Brown B; Schaffer A; Pearson S-A; Simes R, 2022, 'Immune checkpoint inhibitors in advanced non-small cell lung cancer: Real-world survival and safety', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 30 - 31,
    Conference Papers | 2021
    Cohen J; Alvestad S; Suarez E; Schaffer A; Selmer R; Havard A; Bateman B; Zoega H; Kieler H; Odsbu I; Huybrechts K; Kjerpeseth L; Straub L; Leinonen M; Bjork M-H; Norgaard M; Gissler M; Ulrichsen S; Hernandez-Diaz S; Tomson T; Furu K, 2021, 'The Comparative Safety of Antiseizure Medication Polytherapy vs Valproate in Pregnancy and Risk of Major Congenital Malformations', in Pharmacoepidemiology and Drug Safety, John Wiley and Sons, Virtual, pp. 73 - 74, presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Virtual, 23 August 2021 - 25 August 2021
    Conference Abstracts | 2021
    Daniels B; Pearson S-A; Bruno C; Buckley N; Schaffer A; Jun M; Zoega H, 2021, 'Evaluating the impact of new prescribing restrictions for publicy-subsidised proton pump inhibitors in Australia: An interrupted time series analysis', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 219 - 220,
    Conference Presentations | 2021
    Schaffer A; Brett J; Buckley N; Pearson S, 2021, 'Trajectories of Pregabalin Use and Their Association with Longitudinal Changes in Opioid and Benzodiazepine Daily Dose', presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Virtual, 23 August 2021 - 25 August 2021
    Preprints | 2021
    Schaffer A; Henry D; Zoega H; Elliott J; Pearson S-A, 2021, Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia,
    Conference Presentations | 2021
    Schaffer A; Nassar N; Bruno C; Buckley N; Cairns R; Litchfield M; Paget S; Zoega H; Pearson S, 2021, 'Prescribed Medicine Use in a Nationwide Sample of Australian Children: Extent of Off-Label Use', presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Virtual, 23 August 2021 - 25 August 2021
    Conference Papers | 2021
    Tang M; Daniels B; Aslam M; Schaffer AL; Pearson S-A, 2021, 'Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 69 - 70,
    Conference Papers | 2021
    Tang M; Schaffer A; Kiely B; Daniels B; Lee C; Simes J; Pearson S-A, 2021, 'Cardiac assessment in Australian patients receiving trastuzumab for HER2+early breast cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 30 - 30,
    Conference Abstracts | 2021
    Welberry H; Jorm L; Schaffer A; Barbieri S; Hsu B; Harris M; Hall J; Brodaty H, 2021, 'Changing general practitioner when entering residential aged care: impact on psychotropic medicine use and polypharmacy in 2,250 Australians with dementia', in Australian Dementia Forum, presented at Australian Dementia Forum
    Preprints | 2021
    de Oliveira Costa J; Gillies M; Schaffer A; Peiris D; Zoega H; Pearson S-A, 2021, Changes in antidepressant use in Australia: A nationwide analysis prior to and during the COVID-19 pandemic (2015-2021),
    Conference Presentations | 2020
    Carland J; Stocker S; Reuter S; Stacy A; Schaffer A; Stefani M; Lau C; Kirubakaran R; Yang J; Shen C; Roberts D; Marriott D; Day R; Brett J, 2020, 'Evaluation of a pilot vancomycin therapeutic drug monitoring (TDM) service using an interrupted time series analysis', presented at ASCEPT, Virtual, 29 November 2020 - 02 December 2020
    Conference Presentations | 2020
    Schaffer A; Cairns R; Brown J; Gisev N; Buckley N; Pearson S, 2020, 'Changes in sales of over‐the‐counter and prescription medicines after rescheduling of codeine to a prescription‐only medicine in Australia', presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management
    Conference Papers | 2020
    Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson S-A, 2020, 'Changes in sales of over-the-counter and prescription medicines after rescheduling of codeine to a prescription-only medicine in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 142 - 142,
    Conference Abstracts | 2019
    Chiu T; Pearson S; Schaffer A, 2019, 'Pregabalin use outside subsidy restrictions in Australia', in Pharmacoepidemiology and Drug Safety, Wiley, Philadelphia, USA, presented at International Conference on Pharmacoepidemiology, Philadelphia, USA, 24 August 2019 - 28 August 2019,
    Conference Presentations | 2019
    Schaffer A; Buckley N; Pearson S, 2019, 'Unintended Consequences of a National Policy Intervention to Curb Inappropriate Alprazolam Prescribing in Australia', presented at International Conference on Pharmacoepidemiology and Drug Safety, Philadelphia, USA, 24 August 2019 - 28 August 2019,
    Conference Papers | 2019
    Schaffer A; Zoega H; Tran DT; Buckley N; Pearson S; Havard A, 2019, 'Trajectories of antipsychotic use before and during pregnancy and related maternal and birth characteristics', in Pharmacoepidemiology and Drug Safety, Wiley, Philadelphia, USA, pp. 216 - 216, presented at International Conference on Pharmacoepidemiology, Philadelphia, USA, 24 August 2019 - 28 August 2019,
    Conference Abstracts | 2019
    Schaffer AL; Buckley NA; Pearson S, 2019, 'Unintended Consequences of a National Policy Intervention to Curb Inappropriate Alprazolam Prescribing in Australia', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 34 - 35,
    Conference Abstracts | 2019
    Vajdic CM; Perez-Concha O; Rhee J; Dobbins T; Ward R; Schaffer A; Van Leeuwen MT; Laaksonen M; Craigen G; Pearson S, 2019, 'Risk factors for cancer registry-notified cancer of unknown primary site (CUP)', in Asia Pacific Journal of Clinical Oncology, Wiley, Adelaide, Vol. 15, pp. 84 - 85, presented at Clinical Oncology Society of Australia 46th Annual Scientific Meeting, Adelaide, 12 November 2019 - 14 November 2019,
    Conference Abstracts | 2018
    Brieger D; Falster M; Schaffer A; Jorm L; Pearson S; Emerson L; Hay M; Nasis A; Wilson A, 2018, 'P2Y12 Inhibitor Therapy is Underutilised in Patients Hospitalised for Acute Myocardial Infarction: Results From a New Population-Level Data Linkage in Australia', in Heart, Lung and Circulation, Elsevier, Brisbane, Australia, presented at Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Brisbane, Australia
    Conference Abstracts | 2018
    Falster M; Schaffer A; Jorm L; Wilson A; Brieger D; Nasis A; Emerson L; Pearson S, 2018, 'Using Australia’s National Data Linkage Demonstration Project (NDLDP) to improve cardiac care: Towards a national, whole-of-population linked data resource for evidence-informed health policy', in International Journal of Population Data Science, Swansea University, Banff, Canada, Vol. 3, presented at International Population Data Linkage Conference 2018, Banff, Canada,
    Conference Abstracts | 2018
    Nasis A; Schaffer A; Falster M; Pearson S; Jorm L; Emerson L; Hay M; Brieger D; Wilson A, 2018, 'Use of Oral Anticoagulants After Hospital Discharge in Patients With Atrial Fibrillation: Insights From a New Population-Level Linkage in Australia', in Heart, Lung and Circulation, Elsevier, presented at Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand
    Conference Abstracts | 2018
    Reutfors J; Zoega H; Cesta C; Bateman BT; Cantarutti A; Cohen J; Corrao G; Einarsdottir K; Engeland A; Furu K; Havard A; Hernandez-Diaz S; Huybrechts KF; Karlsson P; Karlstad O; Li J; Schaffer A; Yu Y; Broms G, 2018, 'Antipsychotic drug use in pregnancy: A multinational database study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 27, pp. 235 - 235
    Reports | 2018
    Schaffer A; Falster M; Pearson S; Jorm L; Wilson A; Nasis A; Brieger D, 2018, Delivering better cardiac outcomes: Primary, specialist and hospital care
    Conference Presentations | 2017
    Schaffer AL; Buckley NA; Dobbins T; Degenhardt L; Larance B; Pearson SA, 2017, 'Opioid Switching After Introduction of a Tamper-Resistant Oxycodone Formulation in Australia: A Population-Based Study', presented at International Conference on Pharmacoepidemiology, Montreal, Canada, 27 August 2017 - 30 August 2017,
    Conference Presentations | 2017
    Schaffer AL; Buckley NA; Dobbins TA; Degenhardt L; Larance B; Pearson S-A, 2017, 'Opioid Switching After Introduction of a Tamper-Resistant Oxycodone Formulation in Australia: A Population-Based Study', Vol. 26, pp. 212 - 212,
    Conference Abstracts | 2017
    Schaffer AL; Buckley NA; Pearson S, 2017, 'Two-Year Statin Adherence Trajectories in Initiators of Combined Amlodipine-Atorvastatin Therapy: A Population-Based Study (2005–2015)', in Abstracts of the 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, WILEY, Montreal, Canada, Vol. 26, pp. 519 - 520, presented at International Conference on Pharmacoepidemiology, Montreal, Canada, 27 August 2017 - 30 August 2017,
    Reports | 2017
    Zoega H; Schaffer A; Litchfield M; Pearson S, 2017, Post-market Review - Pulmonary Arterial Hypertension Medicines
    Conference Papers | 2016
    Schaffer AL; Pearson S-A; Buckley NA, 2016, 'Does Concordance with Fixed-Dose Combination (FDC) Treatment Guidelines Improve Persistence? An Australian Population Based Cohort Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 292 - 292,
    Conference Posters | 2016
    Schaffer AL; buckley N; cairns R; pearson S, 2016, 'Up-Scheduling of Alprazolam to a “Controlled Drug”: Interrupted Time Series Analysis of Its Impact on Benzodiazepine (BZD) Prescribing, Dispensing and Poisonings in Australia.', Dublin, Ireland, Vol. 25, pp. 346 - 347, presented at 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Dublin, Ireland, 25 August 2016 - 28 August 2016,
    Conference Presentations | 2016
    Schaffer AL; pearson S; buckley N, 2016, 'Does Concordance with Fixed-Dose Combination (FDC) Treatment Guidelines Improve Persistence? An Australian Population Based Cohort Study.', presented at 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Dublin, Ireland, 25 August 2016 - 28 August 2016,
    Conference Presentations | 2016
    joshi V; adelstein BA; Schaffer AL; srasuebkul P; EoCC Investigators ; dobbins T; pearson S, 2016, 'A Proxy of Cancer Progression in Dispensing Claims: Validation and Performance', presented at 29th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Montreal, Canada, 25 August 2016 - 28 August 2016,
    Conference Presentations | 2015
    Schaffer AL; Buckley NA; Dobbins T; Banks E; Pearson S-A, 2015, 'Time Series Analysis of the Impact of Adverse Media on Statin Dispensing and Discontinuation in Australia', Vol. 24, pp. 237 - 238,
    Conference Presentations | 2014
    Vajdic CM; Schaffer A; Dobbins TA; Barrett J; Ward RL; Er CC; Pearson S-A, 2014, 'HEALTH SERVICE UTILISATION AND INVESTIGATIONS BEFORE DIAGNOSIS OF CANCER OF UNKNOWN PRIMARY (CUP): A POPULATION-BASED NESTED CASE-CONTROL STUDY', Vol. 10, pp. 14 - 14,
    Conference Presentations | 2014
    Vajdic CM; Schaffer A; Dobbins TA; Ward RL; Barrett J; Er CC; Pearson S-A, 2014, 'Health service utilisation and investigations before diagnosis of cancer of unknown primary (CUP): A population-based nested case-control study', presented at 2014 World Cancer Congress, Melbourne, 03 December 2014 - 06 December 2014,
    Conference Papers | 2013
    Ganda K; Seibel M; Schaffer A; Pearson S, 2013, 'Adherence to Oral Bisphosphonate Therapy in a Fracture Liaison Service: A Randomised Controlled Trial', in JOURNAL OF BONE AND MINERAL RESEARCH, WILEY-BLACKWELL, MD, Baltimore, presented at Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, MD, Baltimore, 04 October 2013 - 07 October 2013,
    Conference Presentations | 2013
    Schaffer AL; Pearson S-A; Dobbins T; Er C; Meagher NS; Barrett J; Ward RL; Vajdic CM, 2013, 'HEALTH SERVICE USE, TREATMENT PATTERNS, AND SURVIVAL FOR CANCER OF UNKNOWN PRIMARY: A DATA LINKAGE STUDY', Vol. 9, pp. 98 - 98,
    Conference Presentations | 2011
    Schaffer AL; muscatello D; broome R; corbett S; smith W, 2011, 'Excess hospital admissions, ambulance calls and mortality during an exceptional heat wave in February 2011.', Vol. 18, presented at Australasian Epidemiological Association Annual Scientific Meeting, Perth, Australia
    Conference Presentations | 2010
    Schaffer AL; levi C; moore H; rose N; gattelari M; worthington J, 2010, 'Use of linked hospital data to assess the impact of the introduction of tissue plasminogen activator (tPA) therapy on stroke outcomes in NSW.', Vol. 17, presented at Australasian Epidemiological Association 17th Annual Scientific Meeting, Sydney, Australia
    Preprints |
    Schaffer AL; Andrews CD; Brown AD; Croker R; Hulme WJ; Nab L; Quinlan J; Speed V; Wood C; Wiedemann M; Massey J; Inglesby P; Bacon SC; Mehrkar A; Bates C; Goldacre B; Collaborative TO; Walker AJ; MacKenna B, Changes in opioid prescribing during the COVID-19 pandemic in England: cohort study of 20 million patients in OpenSAFELY-TPP,

NHMRC-EU Collaborative Research Grant (CIC, 2021-2023) - "ManagemenT of chronIc cardioMetabolic diseasE and treatment diScontinuity in adult ADHD PAtieNts (TIMESPAN)"

NHMRC Ideas Grant (CIA, 2021-2023)- "Disentangling the interrelationship between multimorbidity, multimedicine use, and cardiovascular health"

NHMRC Project Grant (CIC, 2019-2022)- "Health service and medicine utilisation before suicide: optimising suicide prevention using population-based linkage of routinely collected data"

NHMRC Early Career Fellowship (2019-2022) - "Evaluating population-level medicine policy interventions: generating high-quality evidence about intended and unintended consequences"

NHMRC Post-graduate scholarship (2014-2017)

2019 - UNSW Medicine Early Career Academic Network (ECAN) Best Paper Award, Clinical, Health Services or Public Health category

2019 - Best Paper by an Early Career Researcher (Highly Commended) at the 11th Health Services and Research Association of Australian and New Zealand

2017 - Rising Star Award for best abstract presented by a junior investigator at the 10th Asian Conference on Pharmacoepidemiology

2016 - MJA, MDA National Prize for Excellence in Medical Research for best clinical paper published in the Medical Journal of Australia in 2015

2015 - Stanley A. Edlavitch award for best abstract submitted by a student to the 31stInternational Conference on Pharmacoepidemiology